The Latest on Linked In
Cardio Pod: Heart of the Matter
Episode 1: What is the Heart Failure Collaboratory?
Episode 2: Contemporary Challenges in HF Clinical Trial Design
Episode 3: Statistical Considerations in Heart Failure Research
Episode 4: The Intersection of Heart Failure and the Kidney
Episode 5: Diversity in Heart Failure Clinical Trials
Episode 6: Implications of the Advisory Committee Meetings for the Heart Failure Community
Episode 7: Are we making progress with the recruitment of women in heart failure trials?
Episode 8: DSMB Training Academy: Preparing the Next Generation of Members (Part 1)
Episode 9: DSMB Training Academy: Preparing the Next Generation of Members (Part 2)
HFC in the news
2022 Awardees Recognized at HFSA Annual Scientific Meeting
Ellis Unger Honored with HFC Lifetime Achievement Award
HFC call to action featured in TCTMD
HFC Abstracts Presented at ACC.22
HFC Lean CRF
HFC Lean CRF: Short-Term Mechanical Circulatory Support (MCS) Module
HFC Lean CRF: Magnetic Resonance Imaging Module
HFC Lean CRF: Durable Mechanical Circulatory Support (MCS) Module
HFC Lean CRF: Electrocardiogram Details Module
HFC COVID-19 Data Capture Form
Download the COVID-Like Illness CRF Template
Read the related JACC publication “Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel”.
Return to HFC Communications & Resources
HFC Letter - Impact of COVID-19
Dear Friends and Colleagues,
The mission of the HFC has focused largely on clinical trials, and the impact of COVID-19 on clinical research will be significant. The FDA has issued the following guidance with suggestions and recommendations. We have offered to collect any questions not addressed in the guidance and pass them along on behalf of HFC members. We hope this will be helpful in answering the many questions we are all facing.
Mona Fiuzat, Chris O’Connor, JoAnn Lindenfeld, Bill Abraham, Mitch Psotka, Bram Zuckerman, Norman Stockbridge
Heart Failure Collaboratory Co-Chairs and Members